JPRN-UMIN000017816已完成未知
Study of the anti-tumor effects by oligonucleotides among the patients with primary lung cancer - Study of the anti-tumor effects by oligonucleotides among the patients with primary lung cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Having any treatment for active local or systemic infectious disease 2. Any multiple cancer 3. Needs treatment with systemic corticosteroids or immunosuppressive agents 4. Problematic mental disorder 5. Investigator considers to be inappropriate to participate in this study.
研究者
相似试验
已完成
不适用
Investigation of anti-tumoral effect and safety of combination therapy LD-GP (low dose gemcitabine and paclitaxel) therapy and sorafenib in patients with cisplatin-resistant advanced urothelial cancer.Cisplatin-resistant urothelial cancerJPRN-UMIN000010957agasaki University Hospital15
招募中
1 期
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma.Liver NeoplasmsCarcinoma, HepatocellularDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialHepatocellular carcinomaRPCEC00000022Center of Molecular Immunology (CIM)15
招募中
1 期
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment.Primary malignant colon and breast lesion and metastatic liver lesions.Liver NeoplasmsDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesRPCEC00000023Center of Molecular Immunology (CIM)15
进行中（未招募）
不适用
A study of the effect of Liproca® Depot on prostate cancerEUCTR2011-001137-16-SEIDDS AB28
进行中（未招募）
不适用
A study of the effect of Liproca® Depot on prostate cancerocalized prostate cancerEUCTR2011-001137-16-FIIDDS AB18